Atlas Arteria Limited (ASX:ALX – Get Free Report) announced a final dividend on Friday, March 21st, MarketIndexAU Dividends reports. Shareholders of record on Thursday, April 3rd will be paid a dividend of 0.20 per share on Thursday, April 3rd. This represents a yield of 3.99%. The ex-dividend date of this dividend is Monday, March 24th.
Atlas Arteria Stock Performance
The company has a debt-to-equity ratio of 27.23, a quick ratio of 1.77 and a current ratio of 2.26. The company has a market capitalization of $7.33 billion, a PE ratio of 31.31, a price-to-earnings-growth ratio of 0.31 and a beta of 0.78.
Insider Buying and Selling
In related news, insider David Bartholomew bought 7,700 shares of the business’s stock in a transaction dated Friday, February 28th. The shares were acquired at an average price of A$5.08 ($3.19) per share, for a total transaction of A$39,116.00 ($24,601.26). Also, insider John Wigglesworth purchased 8,000 shares of Atlas Arteria stock in a transaction dated Wednesday, March 5th. The shares were bought at an average cost of A$5.04 ($3.17) per share, for a total transaction of A$40,320.00 ($25,358.49). Over the last 90 days, insiders have acquired 17,450 shares of company stock worth $88,099. 27.61% of the stock is currently owned by corporate insiders.
About Atlas Arteria
Atlas Arteria Limited owns, develops, and operates toll roads. It holds a 31.14% of interest in the APRR and A79 and 31.17% interest in the ADELAC located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago and 100% interest in the Dulles Greenway located in Virginia, United States.
Read More
- Five stocks we like better than Atlas Arteria
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Are Dividend Achievers? An Introduction
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Manufacturing Stocks Investing
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Atlas Arteria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlas Arteria and related companies with MarketBeat.com's FREE daily email newsletter.